Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Shares, without par value
-
Shares outstanding
-
193,394,759
-
Total 13F shares
-
24,017,014
-
Share change
-
+3,813,380
-
Total reported value
-
$66,765,195
-
Price per share
-
$2.78
-
Number of holders
-
47
-
Value change
-
+$11,784,037
-
Number of buys
-
21
-
Number of sells
-
26
Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q4 2019
As of 31 Dec 2019,
Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,017,014 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, Foresite Capital Management IV, LLC, JENNISON ASSOCIATES LLC, Point72 Asset Management, L.P., MORGAN STANLEY, LADENBURG THALMANN FINANCIAL SERVICES INC., COWEN AND COMPANY, LLC, Hudson Bay Capital Management LP, BANK OF MONTREAL /CAN/, and VANGUARD GROUP INC.
This page lists
48
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.